Skip to main content

Table 2 Fat distribution

From: No evidence of a synergistic effect of HIV infection and diabetes mellitus type 2 on fat distribution, plasma adiponectin or inflammatory markers

 

HIV + DM2+

HIV + DM2-

Controls with DM2

Healthy controls

P

Total fat (kg)

25.5 (19.8–31.0)

18.8 (14.1–23.4)

28.9 (25.8–32.0)

21.6 (19.3–24.0)

0.002

Trunk fat (kg)

17.2 (13.5–20.9)

12.4 (8.9–15.9)

18.6 (16.2–21.0)

13.0 (11.5–14.6)*

0.002

Limb fat (kg)

7.5 (5.5–9.5)

5.7 (4.1–7.2)

9.5 (8.4–10.5)

7.9 (6.7–9.1)

0.004

Total fat (%)

28.8 (24.4–33.3)

23.4(19.1–27.7)

34.0 (31.5–36.6)*

28.5 (25.8–31.2)

0.001

Trunk fat (%)

34.3 (29.7–38.8)

28.1 (23.0–33.2)

39.4 (36.8–42.0)*

33.5 (30.9–36.2)

0.001

Limb fat (%)

46.6 (36.3–57.0)

36.5 (28.6–44.5)

58.0 (51.6–64.5)

47.6 (41.4–53.8)

0.002

Trunk fat mass/limb fat mass ratio

2.58 (2.18–2.97)

2.34(1.84–2.85)

2.01 (1.77–2.26)*

1.74 (1.55–1.93)*

0.001

  1. Differences between groups were analyzed using one-way ANOVA followed by t-test for comparison between HIV + DM2+ and the 3 control groups. * p ≤ 0.05 compared to HIV + DM2+. Abbreviations: HIV + DM2+ Persons living with HIV with diabetes mellitus type 2, HIV + DM2- Persons living with HIV without diabetes mellitus type 2